Phaarmasia informs about disclosure

11 Nov 2022 Evaluate
Phaarmasia has informed that the Company is in receipt of the initial public announcement dated 11th November, 2022 made by Saffron Capital Advisors, Manager to the Offer, on behalf of Maneesh Pharmaceuticals, representing the Promoter Group of Phaarmasia (Company) in accordance with Regulation 8 of the SEBI (Delisting of Equity Shares) Regulations 2021, as amended, expressing the intention to voluntary delist the equity shares of the Company (Initial Public Announcement or IPA.

The above information is a part of company’s filings submitted to BSE.

Phaarmasia Share Price

32.36 1.39 (4.49%)
25-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.85
Dr. Reddys Lab 1173.55
Cipla 1525.50
Lupin 2018.35
Zydus Lifesciences 859.10
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...